TY  - JOUR
AU  - Leon-Justel, Antonio
AU  - Morgado Garcia-Polavieja, Jose I
AU  - Alvarez-Rios, Ana Isabel
AU  - Caro Fernandez, Francisco Jose
AU  - Merino, Pedro Agustin Pajaro
AU  - Galvez Rios, Elena
AU  - Vazquez-Rico, Ignacio
AU  - Diaz Fernandez, Jose Francisco
PY  - 2021
DO  - 10.1186/s12955-021-01779-9
UR  - http://hdl.handle.net/10668/17763
T2  - Health and quality of life outcomes
AB  - Heart failure (HF) is a major and growing medical and economic problem, with high prevalence and incidence rates worldwide. Cardiac Biomarker is emerging as a novel tool for improving management of patients with HF with a reduced left ventricular...
LA  - en
KW  - Biomarkers
KW  - Budget impact
KW  - Heart failure
KW  - Patient outcomes
KW  - Patient value
KW  - Personalized medicine
KW  - Aged
KW  - Biomarkers
KW  - Chronic Disease
KW  - Cohort Studies
KW  - Female
KW  - Follow-Up Studies
KW  - Health Care Costs
KW  - Heart Failure
KW  - Hospitalization
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Predictive Value of Tests
KW  - Quality of Life
KW  - Spain
KW  - Ventricular Function, Left
TI  - Biomarkers-based personalized follow-up in chronic heart failure improves patient's outcomes and reduces care associate cost.
TY  - research article
VL  - 19
ER  -